New Analyst Ratings On Cymabay Therapeutics Inc. (CBAY)

Modesto Morganelli
Marzo 28, 2017

Cymabay Therapeutics, Inc. (NASDAQ:CBAY) yearly performance is 205.84%. Analyst's mean target price for CBAY is $5.67 while analysts mean recommendation is 1.80.

Shares of CymaBay Therapeutics Inc (NASDAQ:CBAY) have received an average broker rating score of 0.00 () from the three analysts that cover the company, Zacks Investment Research reports. The company's 50-day moving average price is $3.21 and its 200-day moving average price is $2.20. The current share price indicate that stock is -5.63% away from its one year high and is moving 264.35% ahead of its 52-week low.

On 9/6/2016 Robert James Wills, Director, bought 25,000 with an average share price of $2.43 per share and the total transaction amounting to $60,750.00. The volatility in the previous week has experienced by 8.87% and observed of 9.54% in the previous month.34.00% ownership is held by institutional investors while insiders hold ownership of 5.27%. Given that liquidity is king in short-term, CBAY is a stock with 23.44 million shares outstanding that normally trades 1.81% of its float.

Comcast Corporation (NASDAQ:CMCSA) NBCUniversal announced The Farm Startup Accelerator today, the latest initiative as part of LIFT Labs for Entrepreneurs, a multi-city entrepreneurial support program announced earlier this month. The Farm Startup Accelerator will open applications for its first class later this summer, and the inaugural program will launch in early 2018.

On 24 March 2017, Comcast Corporation (NASDAQ:CMCSA) shares moved to $37.38 after starting the day at $37.24.

08/15/2014 - Cymabay Therapeutics Inc. had its " rating reiterated by analysts at Cowen. Leading up to this report, we have seen a 41.55% rise in the stock price over the last 30 days and a 136.72% increase over the past 3 months.

At the movement Exxon Mobil Corporation (NYSE:XOM) is under coverage by number of analysts.

5/8/2015-Stifel Nicolaus Reiterated Rating of Buy.

Other equities research analysts also recently issued research reports about the stock. Additionally, CBAY had a day price range of $3.79 to $4.33. The company maintains price to book ratio of 9.62 vs.an industry average at 9.86. The stock's market capitalization is 86.52M, it has a 52-week low of 1.02 and a 52-week high of 4.44.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE